Global Apomorphine Hydrochloride Injection Market Insights, Forecast to 2030

Publication ID:

PB512241240

Publication Date:

December 17, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and 伪-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Hydrochloride Injection market is projected to grow from US$ 260.2 million in 2024 to US$ 327.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
Report Covers:
This report presents an overview of global market for Apomorphine Hydrochloride Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Apomorphine Hydrochloride Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Apomorphine Hydrochloride Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Apomorphine Hydrochloride Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Apomorphine Hydrochloride Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Apomorphine Hydrochloride Injection sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Ever Pharma
Evolan Pharma AB (PharmSwed)
Segment by Type
Pen Injectors
Infusion Pumps
Segment by Application
Parkinson Disease
Erectile Dysfunction
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Apomorphine Hydrochloride Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Apomorphine Hydrochloride Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apomorphine Hydrochloride Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Apomorphine Hydrochloride Injection Product Introduction
1.2 Market by Type
1.2.1 Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pen Injectors
1.2.3 Infusion Pumps
1.3 Market by Application
1.3.1 Global Apomorphine Hydrochloride Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Apomorphine Hydrochloride Injection Sales Estimates and Forecasts 2019-2030
2.2 Global Apomorphine Hydrochloride Injection Revenue by Region
2.2.1 Global Apomorphine Hydrochloride Injection Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Apomorphine Hydrochloride Injection Revenue by Region (2019-2024)
2.2.3 Global Apomorphine Hydrochloride Injection Revenue by Region (2025-2030)
2.2.4 Global Apomorphine Hydrochloride Injection Revenue Market Share by Region (2019-2030)
2.3 Global Apomorphine Hydrochloride Injection Sales Estimates and Forecasts 2019-2030
2.4 Global Apomorphine Hydrochloride Injection Sales by Region
2.4.1 Global Apomorphine Hydrochloride Injection Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Apomorphine Hydrochloride Injection Sales by Region (2019-2024)
2.4.3 Global Apomorphine Hydrochloride Injection Sales by Region (2025-2030)
2.4.4 Global Apomorphine Hydrochloride Injection Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Apomorphine Hydrochloride Injection Sales by Manufacturers
3.1.1 Global Apomorphine Hydrochloride Injection Sales by Manufacturers (2019-2024)
3.1.2 Global Apomorphine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Apomorphine Hydrochloride Injection in 2023
3.2 Global Apomorphine Hydrochloride Injection Revenue by Manufacturers
3.2.1 Global Apomorphine Hydrochloride Injection Revenue by Manufacturers (2019-2024)
3.2.2 Global Apomorphine Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Apomorphine Hydrochloride Injection Revenue in 2023
3.3 Global Key Players of Apomorphine Hydrochloride Injection, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Apomorphine Hydrochloride Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Apomorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Product Offered and Application
3.8 Global Key Manufacturers of Apomorphine Hydrochloride Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Apomorphine Hydrochloride Injection Sales by Type
4.1.1 Global Apomorphine Hydrochloride Injection Historical Sales by Type (2019-2024)
4.1.2 Global Apomorphine Hydrochloride Injection Forecasted Sales by Type (2025-2030)
4.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Type (2019-2030)
4.2 Global Apomorphine Hydrochloride Injection Revenue by Type
4.2.1 Global Apomorphine Hydrochloride Injection Historical Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Hydrochloride Injection Forecasted Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
4.3 Global Apomorphine Hydrochloride Injection Price by Type
4.3.1 Global Apomorphine Hydrochloride Injection Price by Type (2019-2024)
4.3.2 Global Apomorphine Hydrochloride Injection Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Apomorphine Hydrochloride Injection Sales by Application
5.1.1 Global Apomorphine Hydrochloride Injection Historical Sales by Application (2019-2024)
5.1.2 Global Apomorphine Hydrochloride Injection Forecasted Sales by Application (2025-2030)
5.1.3 Global Apomorphine Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Apomorphine Hydrochloride Injection Revenue by Application
5.2.1 Global Apomorphine Hydrochloride Injection Historical Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Hydrochloride Injection Forecasted Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Apomorphine Hydrochloride Injection Price by Application
5.3.1 Global Apomorphine Hydrochloride Injection Price by Application (2019-2024)
5.3.2 Global Apomorphine Hydrochloride Injection Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Apomorphine Hydrochloride Injection Market Size by Type
6.1.1 US & Canada Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
6.1.2 US & Canada Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
6.2 US & Canada Apomorphine Hydrochloride Injection Market Size by Application
6.2.1 US & Canada Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
6.2.2 US & Canada Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
6.3 US & Canada Apomorphine Hydrochloride Injection Market Size by Country
6.3.1 US & Canada Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
6.3.3 US & Canada Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Apomorphine Hydrochloride Injection Market Size by Type
7.1.1 Europe Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
7.1.2 Europe Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
7.2 Europe Apomorphine Hydrochloride Injection Market Size by Application
7.2.1 Europe Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
7.2.2 Europe Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
7.3 Europe Apomorphine Hydrochloride Injection Market Size by Country
7.3.1 Europe Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
7.3.3 Europe Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Apomorphine Hydrochloride Injection Market Size
8.1.1 China Apomorphine Hydrochloride Injection Sales (2019-2030)
8.1.2 China Apomorphine Hydrochloride Injection Revenue (2019-2030)
8.2 China Apomorphine Hydrochloride Injection Market Size by Application
8.2.1 China Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
8.2.2 China Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Apomorphine Hydrochloride Injection Market Size by Type
9.1.1 Asia Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
9.1.2 Asia Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
9.2 Asia Apomorphine Hydrochloride Injection Market Size by Application
9.2.1 Asia Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
9.2.2 Asia Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
9.3 Asia Apomorphine Hydrochloride Injection Sales by Region
9.3.1 Asia Apomorphine Hydrochloride Injection Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Apomorphine Hydrochloride Injection Revenue by Region (2019-2030)
9.3.3 Asia Apomorphine Hydrochloride Injection Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Apomorphine Hydrochloride Injection Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Supernus Pharmaceuticals
11.1.1 Supernus Pharmaceuticals Company Information
11.1.2 Supernus Pharmaceuticals Overview
11.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Supernus Pharmaceuticals Recent Developments
11.2 Britannia Pharmaceuticals STADA
11.2.1 Britannia Pharmaceuticals STADA Company Information
11.2.2 Britannia Pharmaceuticals STADA Overview
11.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Britannia Pharmaceuticals STADA Recent Developments
11.3 Ever Pharma
11.3.1 Ever Pharma Company Information
11.3.2 Ever Pharma Overview
11.3.3 Ever Pharma Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Ever Pharma Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ever Pharma Recent Developments
11.4 Evolan Pharma AB (PharmSwed)
11.4.1 Evolan Pharma AB (PharmSwed) Company Information
11.4.2 Evolan Pharma AB (PharmSwed) Overview
11.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Apomorphine Hydrochloride Injection Industry Chain Analysis
12.2 Apomorphine Hydrochloride Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Apomorphine Hydrochloride Injection Production Mode & Process
12.4 Apomorphine Hydrochloride Injection Sales and Marketing
12.4.1 Apomorphine Hydrochloride Injection Sales Channels
12.4.2 Apomorphine Hydrochloride Injection Distributors
12.5 Apomorphine Hydrochloride Injection Customers
13 Market Dynamics
13.1 Apomorphine Hydrochloride Injection Industry Trends
13.2 Apomorphine Hydrochloride Injection Market Drivers
13.3 Apomorphine Hydrochloride Injection Market Challenges
13.4 Apomorphine Hydrochloride Injection Market Restraints
14 Key Findings in The Global Apomorphine Hydrochloride Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂